| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pixium Vision SA (PA: ALPIX)
ALPIX Technical Analysis
5
| As on 9th Jun 2023 ALPIX STOCK Price closed @ 0.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.43 & Strong Sell for SHORT-TERM with Stoploss of 0.71 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALPIXSTOCK Price
| Open | 0.07 | Change | Price | % |
| High | 0.07 | 1 Day | 0.00 | 0.00 |
| Low | 0.07 | 1 Week | 0.00 | 0.00 |
| Close | 0.07 | 1 Month | -0.01 | -12.50 |
| Volume | 1690880 | 1 Year | -0.76 | -91.57 |
| 52 Week High 0.86 | 52 Week Low 0.03 | ||||
PA France Most Active Stocks
| FTI | 5.91 | -1.66% |
| VIEDS | 0.72 | 4.35% |
| ALDRV | 0.01 | 0.00% |
| AF | 1.73 | 1.76% |
| CGG | 0.69 | -2.82% |
| ALVMG | 0.50 | 0.00% |
| ACA | 10.83 | -0.91% |
| ALJXR | 0.01 | 0.00% |
| CS | 26.52 | -2.00% |
| GLE | 23.32 | 1.92% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
| ALPIX Daily Charts |
ALPIX Intraday Charts |
Whats New @ Bazaartrend |
ALPIX Free Analysis |
|
|
ALPIX Important Levels Intraday
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
ALPIX Forecast April 2024
| 4th UP Forecast | 0.61 |
| 3rd UP Forecast | 0.44 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.22 |
| 1st DOWN Forecast | -0.08 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.3 |
| 4th DOWN Forecast | -0.47 |
ALPIX Weekly Forecast
| 4th UP Forecast | 0.20 |
| 3rd UP Forecast | 0.16 |
| 2nd UP Forecast | 0.13 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -0.06 |
ALPIX Forecast2024
| 4th UP Forecast | 1.69 |
| 3rd UP Forecast | 1.17 |
| 2nd UP Forecast | 0.85 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | -0.39 |
| 2nd DOWN Forecast | -0.71 |
| 3rd DOWN Forecast | -1.03 |
| 4th DOWN Forecast | -1.55 |
Pixium Vision SA ( PA France Symbol : ALPIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALPIX Business Profile
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France. Address: 74 rue du Faubourg Saint-Antoine, Paris, France, 75012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service